Harpoon Therapeutics

-$0.02 (-1.01%) Today
+$0.01 (+0.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HARP and other ETFs, options, and stocks.

About HARP

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.

CEO
Julia Marie Eastland
Employees
99
Headquarters
South San Francisco, California
Founded
2015

HARP Key Statistics

Market cap
65.18M
Price-Earnings ratio
—
Dividend yield
—
Average volume
413.63K
High today
$2.05
Low today
$1.94
Open price
$1.99
Volume
187.68K
52 Week high
$22.74
52 Week low
$1.73

HARP Earnings

-$0.66
-$0.56
-$0.47
-$0.37
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.54 per share
Actual
-$0.62 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure